Rubicon Global Research Provides Specific Coverage on Company Events.PORTLAND, Ore. -- RESEARCH ALERT -- Upcoming fundamental events. Rubicon Global Research is providing research coverage on companies with upcoming events for specific drugs. Insmed Inc., GlaxoSmithKline plc., Pfizer Inc., Cephalon Inc., and Abbott Laboratories have specific near-term events. Event timing is as follows: Nasdaq:INSM INSM Initiative Neue Soziale Marktwirtschaft (German) INSM Integrated Network and Systems Management : October 3, 2005 NYSE NYSE See: New York Stock Exchange :GSK: October 6, 2005 NYSE:PFE: October 7, 2005 Nasdaq:CEPH: October 8, 2005 NYSE:ABT: October 14, 2005 Each report covers: --Specific details of the event that may include panel meetings, FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. decisions, and presentation of clinical data --The expected outcome for the event --Specific drug details regarding; disease treatment, competitive therapies, and market size (patient population) --Company summary financials A report on each company event was published by Rubicon Global Research, LLC and is currently available for individual sale or through a subscription. In addition, a comprehensive calendar of upcoming events is available along with a performance summary report showing past event results. Further details on these reports and many others may be found at our web site: www.rubiconglobalresearch.com Rubicon Global Research, LLC is a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of Rubicon Global Holdings, LLC, a registered NASD NASD See: National Association of Securities Dealers NASD See National Association of Securities Dealers (NASD). company. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion